NSE: BAYERCROP | BSE: 506285

Expensive Performer

Download real time

5202.00 -0.50 (-0.01%)

1,747 NSE+BSE Volume

NSE 03 Sep, 2025 9:32 AM (IST)

23,378.9

Market Cap

High in industry

0.7

Beta 1Year

Very Low volatility

Bayer Cropscience Ltd. share price target and research reports

Name: Latest research reports of Bayer Cropscience Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Bayer Cropscience Ltd.
Rating: 3
Author: Axis Direct

Latest analyst research reports with target prices and PDF download for BAYERCROP, BSE:506285 Bayer Cropscience Ltd.

Bayer Cropscience Ltd.

29 May 2017

5202.00

-0.01%

Bayer CropScience Ltd Q4FY17 results comment

Results Update: Bayer Cropscience Ltd.

HDFC Securities

Revenue fell by 67.5% to Rs. 215.3 Cr in Q4FY17 when compared to the previous quarter.

Number of FII/FPI investors increased from 198 to 207 in Jun 2025 qtr.

Bayer Cropscience Ltd.

24 May 2017

5202.00

-0.01%

Bayer reported a sharp 50% yoy drop in revenues to Rs2.4bn and below our estimate of Rs4...

Hold: Bayer Cropscience Ltd.

Target

Emkay

Bayer reported a sharp 50% yoy drop in revenues to Rs2.4bn and below our estimate of Rs4.7bn (after adjusting for Ind-AS) and is also below consensus estimates. Revenue was impacted due to weak season in South India which constitutes 65% of Q4 sales Gross margins improved 430bps yoy to 44.6% benefiting from lower RM cost. However, Company reported EBITDA loss of Rs581mn vs. a profit of Rs 205mn in Q4FY16 Loss at...

Bayer Cropscience Ltd. is trading below all available SMAs

Bayer Cropscience Ltd.

17 Feb 2017

5202.00

-0.01%

Visit Note:Bayer Crop Sci.

Hold: Bayer Cropscience Ltd.

Axis Direct

Bayer's management expects CY17 to be a challenging year due to lower reservoir levels, high channel inventories and poor farmer liquidity;however, firm commodity prices and one goodagri-seasonare sufficient to address these issues. Despite challenges, Bayer's domestic revenue grew 16% YoY in 9M..

Bayer Cropscience Ltd. has lost -16.83% in the last 1 Month

Bayer Cropscience Ltd.

24 Sep 2015

5202.00

-0.01%

Bayer Cropscience Ltd: Return of Capital to Shareholders the Major Trigger (Sep 24, 2015)

Sell: Bayer Cropscience Ltd.

Karvy

Increasing proportion of manufactured goods in the overall revenue from 43%in FY15 to 44% in FY17E is expected to lead to a 20 basis points jump in grossmargins from 64.8% in FY15 to 65.0% in FY16E & FY17E. It could have been higher, if not for the weak macro-industry environment. This increase is expected to act as a cushion for the EBITDA margins going forward. But, significant dependence on traded goods will continue to act as a ceiling for margins. We expect EBITDA margins to remain stable at lower levels of 11.9% & 12.3% in FY16E & FY17E respectively.

Number of FII/FPI investors increased from 198 to 207 in Jun 2025 qtr.

Is Bayer Cropscience Ltd. worth buying?

118 Votes:

Buy 80.51%

Sell 11.86%

Hold 7.63%